Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Failure, Chronic: early-phase trial registry
5 of 25 indexed Kidney Failure, Chronic trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #652 of 28,707 conditions by registered trial count.
25 US clinical trials · 5 currently recruiting · #652 of 28,707 conditions by registered trial count
Kidney Failure, Chronic: 25 US clinical trials tracked, 5 recruiting.
Kidney Failure, Chronic is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most active sponsor is NxStage Medical, running 2 of these trials.
Enrollment posture brief
Registry condition kidney-failure-chronic
OPEN 5 | RECR 20% | LATE 3 | EARLY 11 | RANK #652 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Kidney Failure, Chronic lists 5 open slots (20% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Failure, Chronic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Failure, Chronic is recruiting below its size-band peers.
5 of 25 indexed trials (20%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Kidney Failure, Chronic trials is spread across many organizations.
NxStage Medical accounts for 2 of 25 trials (8%). 22 distinct sponsors appear on at least one study for this condition label.
-
Most Kidney Failure, Chronic trials plan to enrol fewer than 100 people.
Median target enrolment is 58 among the 24 trials that report a genuine target (sentinel values excluded). 16 of those (66.7%) plan for fewer than 100 participants.
-
Kidney Failure, Chronic research is mostly interventional.
21 interventional and 4 observational studies make up this index (84% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
25 total, page 1 of 1
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
The Rogosin Institute
NCT01802034
International (Pediatric) Peritoneal Biobank
Heidelberg University
NCT01893710
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Alessandro Doria
NCT06217302
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Eli Lilly and Company
NCT07426380
Empagliflozin in ESKD - A Feasibility Study
University of Mississippi Medical Center
NCT05687058
Kidney Function in Sickle Cell Anemia
Kenneth Ataga MD
NCT03277547
DePTH: De-emphasize PTH
University of Washington
NCT06288451
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
Stanley Jordan, MD
NCT03380962
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
University of Washington
NCT04281784
Multidisciplinary Inpatient Palliative Care Intervention
Kaiser Permanente
NCT00325611
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
Merck Sharp & Dohme
NCT05027074
FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
NxStage Medical
NCT00288613
Exercise Intolerance in Renal Failure
Emory University
NCT01356966
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
NxStage Medical
NCT00667511
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
Palo Alto Veterans Institute for Research
NCT03874117
Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes
Stanford University
NCT01186276
A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function
Janssen Research & Development
NCT03546205
Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)
Merck Sharp & Dohme
NCT03873038
Exercise in Peritoneal Dialysis Patients (PDEX)
Satellite Healthcare
NCT03980795
Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
Shire
NCT00875017
A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
Hoffmann-La Roche
NCT02586051
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
Hansa Biopharma AB
NCT02790437
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
Oregon Health and Science University
NCT00212758
Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
Weill Medical College of Cornell University
NCT00629122
Resistance Training and Diet in Patients With Chronic Renal Failure
US Department of Veterans Affairs
NCT00018317
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Failure, Chronic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Failure, Chronic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Failure, Chronic page
25 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Kidney Failure, Chronic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- NxStage Medical sponsors the most Kidney Failure, Chronic trials on record, review their full trial history before evaluating a specific study. See NxStage Medical's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Failure, Chronic condition card totals 25 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.